Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy

被引:1
作者
Zhang, Tingting [1 ]
Yang, Yushan [1 ]
Huang, Li [1 ]
Liu, Ying [1 ]
Chong, Gaowei [1 ]
Yin, Weimin [1 ]
Dong, Haiqing [2 ]
Li, Yan [1 ]
Li, Yongyong [1 ]
机构
[1] Tongji Univ, Shanghai Skin Dis Hosp, Sch Med, Shanghai 200092, Peoples R China
[2] Tongji Univ, Sch Med, Tongji Hosp, Minist Educ,Key Lab Spine & Spinal Cord Injury Re, Shanghai 200092, Peoples R China
基金
中国国家自然科学基金;
关键词
immune cell; biomimetic engineering; materials-potentiated cell engineering; cancer immunotherapy; ANTIGEN-PRESENTING CELLS; INHIBIT TUMOR-GROWTH; NATURAL-KILLER-CELLS; T-CELLS; DENDRITIC CELLS; GRANULOCYTE TRANSFUSION; IMMUNE-RESPONSE; NK CELLS; NANOPARTICLES; ACTIVATION;
D O I
10.3390/pharmaceutics14040734
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In cancer immunotherapy, immune cells are the main force for tumor eradication. However, they appear to be dysfunctional due to the taming of the tumor immunosuppressive microenvironment. Recently, many materials-engineered strategies are proposed to enhance the anti-tumor effect of immune cells. These strategies either utilize biomimetic materials, as building blocks to construct inanimate entities whose functions are similar to natural living cells, or engineer immune cells with functional materials, to potentiate their anti-tumor effects. In this review, we will summarize these advanced strategies in different cell types, as well as discussing the prospects of this field.
引用
收藏
页数:27
相关论文
共 133 条
[1]   Neutrophil-inspired propulsion in a combined acoustic and magnetic field [J].
Ahmed, Daniel ;
Baasch, Thierry ;
Blondel, Nicolas ;
Laubli, Nino ;
Dual, Jurg ;
Nelson, Bradley J. .
NATURE COMMUNICATIONS, 2017, 8
[2]   SIRPA-Inhibited, Marrow-Derived Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid Tumors [J].
Alvey, Cory M. ;
Spinler, Kyle R. ;
Irianto, Jerome ;
Pfeifer, Charlotte R. ;
Hayes, Brandon ;
Xia, Yuntao ;
Cho, Sangkyun ;
Dingal, P. C. P. Dave ;
Hsu, Jake ;
Smith, Lucas ;
Tewari, Manu ;
Discher, Dennis E. .
CURRENT BIOLOGY, 2017, 27 (14) :2065-+
[3]   Clinical use of dendritic cells for cancer therapy [J].
Anguille, Sebastien ;
Smits, Evelien L. ;
Lion, Eva ;
van Tendeloo, Viggo F. ;
Berneman, Zwi N. .
LANCET ONCOLOGY, 2014, 15 (07) :E257-E267
[4]   The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies [J].
Bald, Tobias ;
Krummel, Matthew F. ;
Smyth, Mark J. ;
Barry, Kevin C. .
NATURE IMMUNOLOGY, 2020, 21 (08) :835-847
[5]   CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy [J].
Barkal, Amira A. ;
Brewer, Rachel E. ;
Markovic, Maxim ;
Kowarsky, Mark ;
Barkal, Sammy A. ;
Zaro, Balyn W. ;
Krishnan, Venkatesh ;
Hatakeyama, Jason ;
Dorigo, Oliver ;
Barkal, Layla J. ;
Weissman, Irving L. .
NATURE, 2019, 572 (7769) :392-+
[6]   Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects [J].
Bassani, Barbara ;
Baci, Denisa ;
Gallazzi, Matteo ;
Poggi, Alessandro ;
Bruno, Antonino ;
Mortara, Lorenzo .
CANCERS, 2019, 11 (04)
[7]   Safety and immunologic effects of IL-15 administration in nonhuman primates [J].
Berger, Carolina ;
Berger, Michael ;
Hackman, Robert C. ;
Gough, Michael ;
Elliott, Carole ;
Jensen, Michael C. ;
Riddell, Stanley R. .
BLOOD, 2009, 114 (12) :2417-2426
[8]   Cancer SLC43A2 alters T cell methionine metabolism and histone methylation [J].
Bian, Yingjie ;
Li, Wei ;
Kremer, Daniel M. ;
Sajjakulnukit, Peter ;
Li, Shasha ;
Crespo, Joel ;
Nwosu, Zeribe C. ;
Zhang, Li ;
Czerwonka, Arkadiusz ;
Pawlowska, Anna ;
Xia, Houjun ;
Li, Jing ;
Liao, Peng ;
Yu, Jiali ;
Vatan, Linda ;
Szeliga, Wojciech ;
Wei, Shuang ;
Grove, Sara ;
Liu, J. Rebecca ;
McLean, Karen ;
Cieslik, Marcin ;
Chinnaiyan, Arul M. ;
Zgodzinski, Witold ;
Wallner, Grzegorz ;
Wertel, Iwona ;
Okla, Karolina ;
Kryczek, Ilona ;
Lyssiotis, Costas A. ;
Zou, Weiping .
NATURE, 2020, 585 (7824) :277-+
[9]   Principles of nanoparticle design for overcoming biological barriers to drug delivery [J].
Blanco, Elvin ;
Shen, Haifa ;
Ferrari, Mauro .
NATURE BIOTECHNOLOGY, 2015, 33 (09) :941-951
[10]  
Briones Michael A, 2003, Curr Hematol Rep, V2, P522